Philip Morris
Review 890000 Alice Hamilton Lecture Lead and Human Health:Background and Recent Findings
Fields
- Author
- Lippmann, M.
- Area
- LOGUE,MAYADA/OFFICE
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- CHAR, CHART, GRAPH, TABLE, MAPS
- DRAW, DRAWING
- BIBL, BIBLIOGRAPHY
- Site
- N426
- Request
- Stmn/R1-072
- Named Organization
- NCI, Natl Cancer Inst
- Niehs, National Institute of Environmental Health Services/Sciences
- Niosh, Natl Inst for Occupational Safety & Health
- Niehs, National Institute of Environmental Health Services/Sciences
- Named Person
- Hamilton, A.
- Document File
- 2025545619/2025546382/Harvard University Office of
- Continuing Education Short Course Program Harvard School
- of Public Health
- Continuing Education Short Course Program Harvard School
- Litigation
- Stmn/Produced
- Author (Organization)
- Environmental Research
- Inst of Environmental Medicine
- Ny Univ
- Inst of Environmental Medicine
- Master ID
- 2025545673/6381
Related Documents:- 2025545673-6381 Risk Analysis in Occupational and Environmental Health 910904 - 910906
- 2025545684 Telephone Locations and Protocol
- 2025545689-5696 Risk Assessment for Carcinogens: A Comparison of Approaches of the Acgih and the Epa
- 2025545697 Hps Newsletter Interview with A Risk Expert
- 2025545698-5711 Science and Its Limits: the Regulator's Dilemma
- 2025545713-5721 Risk / Benefit Analysis
- 2025545722-5725 Risk Management Commentary for Dr. D. Allan Bromley Assistant to the President for Science and Technology
- 2025545726-5729 Risk Assessment and Comparisons: An Introduction
- 2025545750-5792 Risk Assessment of Chemical Carcinogens: Is It Time for A Change?
- 2025545795-5799 Tools of Risk Analysis Applications of Epidemiology
- 2025545800-5810 Notice of Intended Changes - Benzene
- 2025545811-5822 Epidemiology in Risk Assessment for Regulatory Policy
- 2025545824-5850 Risk Analysis in Environmental and Occupational Health Use of Animal and Other Data As Predictors of Human Risk
- 2025545851-5871 Risk Analysis in Environmental and Occupational Health Uncertainties in Predicting Human Risks
- 2025545872-5881 How Do Cancer Risks Predicted From Animal Bioassays Compare with the Epidemiologic Evidence? the Case of Ethylene Dibromide
- 2025545882-5887 Use of Biological Assays in Short-Term Assessment of Inhaled Substances
- 2025545888
- 2025545889-5891 Risk Analysis in Environmental and Occupational Health Are Your Mushrooms Safe to Eat?
- 2025545892-5899 the Rat As An Experimental Animal
- 2025545901-5907 Non-Cancer Endpoints
- 2025545910-5939 Cancer Facts & Figures - 890000
- 2025545940-5941 Cancer Facts & Figures - 890000
- 2025545942-5944 Get - the - Lead - Out Guru Challenged A Decade-Old Scientific Argument Over the Effects of Low-Level Lead on Iq Turns Nasty Following Allegations of Misconduct
- 2025545945-5948
- 2025545949-5958 the Question of Thresholds for Radiation and Chemical Carcinogenesis
- 2025545959-5980 Are There Thresholds for Carcinogenesis? the Thorny Problem of Low-Level Exposure
- 2025545981-5990 Perspectives on Comparing Risks of Environmental Carcinogens
- 2025545991-5998 Acceptable Cancer Risks: Probabilities and Beyond
- 2025546000-6011 Ideas in Pathology Pivotal Role of Increased Cell Proliferation in Human Carcinogenesis
- 2025546012-6017 Cell Proliferation in Carcinogenesis
- 2025546019-6027 the Role of Expert Judgement in Risk Analysis
- 2025546029-6039 the Respiratory Tract As A Route of Exposure
- 2025546040-6045 the Respiratory Tract As A Portal of Entry for Toxic Particles
- 2025546047-6062 Limitations to the Use of Employee Exposure Data on Air Contaminants in Epidemiologic Studies
- 2025546063-6083 Benefit - Cost Analysis of Environmental Regulation: Case Studies of Hazardous Air Pollutants
- 2025546086-6089 Legislative and Regulatory Aspects of Risk
- 2025546090-6099 Connecticut's Dioxin Ambient Air Quality Standard
- 2025546100-6103
- 2025546105 Annals of Radiation Calamity on Meadow Street
- 2025546106 Caution Urged When Using Insect Repellents
- 2025546116 Volatile Organics and Inorganics Action Levels 900400
- 2025546134-6135 Summary of Radon Test Results of the Household Testing Program
- 2025546141-6145 Introduction to Discussion Sessions
- 2025546146-6149 Risk Assessment in Environmental and Occupational Health Risk of Alar (Daminozide)
- 2025546150-6160 Intolerable Risk: Pesticides in Our Children's Food
- 2025546161-6162 Pesticides, Risk, and Applesauce
- 2025546163-6168 Daminozide Special Review Technical Support Document - Preliminary Determination to Cancel the Food Uses of Daminozide
- 2025546169 Daminozide / Udmh
- 2025546170-6172 the Relative Risk of Daminozide (Alar / Kylar) Use
- 2025546173 Be Most Wary of Nature's Own Pesticides
- 2025546174-6175 A Movie Star Pares the Apple Industry
- 2025546176-6183 Summary of Toxicology Data on Daminozide and Udmh
- 2025546184-6194 Attachment I Graphs of Data From NCI / Ntp 83 Daminozide
- 2025546195-6196
- 2025546197-6202 Daminozide Special Review Technical Support Document - Preliminary Determination to Cancel the Food Uses of Daminozide
- 2025546203-6224 Regulatory Decision - Making Under Uncertainty: the Case of Alar
- 2025546226 Epa Moves to Reassess the Risk of Dioxin Urged on by the Scientific Community, Epa Is Developing A New Model for Estimating Dioxin's Risk
- 2025546227 US Government Orders New Look at Dioxin the Environmental Protection Agency Is Evaluating Data From the Past Decade That Suggest Dioxin's Toxicity May Be Overestimated. A Risk Assessment Model Based on Biological Mechanism Is Being Drawn Up.
- 2025546228-6235 Dioxin Toxicity: New Studies Prompt Debate, Regulatory Action New Data on Dioxin's Effect on Humans, A Clearer Picture of the Cellular Events It Precipitates, and New Animal Toxicity Studies May Provide Epa with A Firm Basis for Regulation
- 2025546236-6250 the Regulation of Gene Expression by 2,3,7, 8-Tetrachlorodibenzo-P-Dioxin
- 2025546251-6253 Dioxin Risks Revisited Armed with A New Understanding of How Dioxin Works on the Molecular Level, A Number of Scientists Are Challenging Epa to Change the Way It Does Risk Assessment
- 2025546255-6258 Lead Toxicity Case Study for Short Course on Risk Analysis in Occupational and Environmental Health 910904 - 910906
- 2025546259-6267 Lead
- 2025546268-6275 Lead in Bone: Implications for Toxicology During Pregnancy and Lactation
- 2025546276-6281 the Long-Term Effects of Exposure to Low Doses of Lead in Childhood An 11 - Year Follow-Up Report
- 2025546282-6285
- 2025546323-6348 Traps and Errors in Risk Analysis
- 2025546349-6356 Health Risks the Perception of Reality and the Realty of Perception
- 2025546357-6362 Communicating Risk Under Title III of Sara: Strategies for Explaining Very Small Risks in A Community Context
- 2025546363-6368 Industrial Risk Perceptions
- 2025546369-6370 Too Many Rodent Carcinogens: Mitogenesis Increases Mutagenesis
- 2025546371-6373 Has Risk Assessment Become Too 'conservative'?
- 2025546374-6378 Health and Safety Risk Analyses: Information for Better Decisions
- 2025546379-6381 Telling Reporters About Risk Dealing with Reporters Needn't Be the Least Agreeable Part of the Job.
- Characteristic
- EXTR, EXTRA
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- jmp02a00
Document Images
LEAD AND HUMAN HEALTH
1I
following appropriate adjustments, with deficits in reaction time under varying
intervals, which is an index of attentiveness, and with reaction behavior. The 1986
EPA criteria document concluded that these findings argue for probable effects of
lead on attention and vigilance functions at PbB levels extending below 30 µg/dl,
and possibly, down to as low as 15-20 p.g/dl.
There is also evidence that low levels of lead may be associated with effects on
some complex cognitive functions including learning, visual-perception skills,
and IQ scores. The studies on children have attracted controversy because of
d'afficulties associated with attributing subtle deficits in child development to lead
exposure rather than to effects due to genetics, nutrition, medical history, access
to education, and parental and social_influences, all of which interact in potentially
complex ways to mold an individual.
On the basis of five methodological criteria (adequate markers of lead exposure,
sensitive measures of neurobehavioral function, appropriate subject selection,
control of confounding covariates, and appropriate statistical analysis), the 1986
EPA criteria document identified a group of neurobehavioral studies that were
conducted rigorously enough to warrant at least some consideration. The general
indication from the better investigations is that PbB levels persistently elevated in
the range of 50-70 µg/dI tend to be associated with about a 5-point reduction in IQ,
even among asymptomatic children and after controlling for potentially confound-
ing variables.
However, considerable uncertainty has existed regarding lead's impact on IQ
scores of children with PbB levels below 40 µg/dl. This uncertainty stems largely
from the complex interaction between lead exposure over time, social factors, and
intelligence scores, from the statistical and methodological limitations of cross-
sectional studies to untangle these variables, and the range of interpretations that
result from these studies.
1°he 1986 EPA criteria document concluded from the Needleman et ol. (1979)
stpdy and subsequent reanalyses (Needleman, 1984) that, after controlling for
coitfounding variables including pica, average IQ decrements of about 4 points
and other neurobehavioral deficits appear to be associated with lead exposures of
U.S. children resulting in dentine lead values that exceed 20-30 ppm and likely
average PbB levels in the 30-SO µg/dl range. Needleman et al. (1982) calculated
that a 4-point decrement in the mean IQ of a normal population distribution would
be'associated with a threefold increase in the number of children with severe
defcits (IQ < 80) along with a 5% reduction in the number of children who attain
superior function (IQ > 125) (see Fig. 6).
In order to avoid the normal array of confounding factors, Bellinger rt al. (1987)
performed a longitudinal analysis of prenatal and postnatal lead exposure and
early cognitive development in 249 children. In general, the infants were healthy
products of unremarkable pregnancies, with few of the characteristics of infants at
increased risk of developmental handicap. Eighty-seven percent of the families
were white, and 92% were intact. The differences among the families with infants
in the three cord-blood lead groups were slight and generally not in the direction
expected on the basis of studies of the social correlates of childhood lead expo-
sure. On the basis of lead levels in umbilical-cord blood, children were assigned

12
100
0
MORTON LIPPMANN
0
1E]
60 80 100
VERBAL 1.A.
0
120
140
FtG. 6. Cumulative frequency distribution of verbal IQ scores in subjects with low or hi$h levels of
lead (Pdeedleman et aL, 1982).
to one of three prenatal-exposure groups: low (<3 µg/dl), medium (6 to 7 µg/dl),
or high (;~--10 µg/dl). Development was assessed semiannually, beginning at the
age of 6 months, with use of the Mental Development Index of the Bayley Scales
of Infant Development.
Regression methods for longitudinal data were used to evaluate the association
between infants' lead levels and their development scores after adjustment for
potential confounders. At all ages, infants in the high-prenatal-exposure group
scored lower than infants in the other two groups. The results are summarized in
Fig. 7. Scores were not related to infants' postnatal blood lead levels.
McMichael rt al. (1988) studied the effect of environmental exposure to lead on
children's abilities at the age of 4 years in a cohort of 537 children born during 1979
to 1932 to women living in a community situated near a lead smelter at Port Pirie
in Australia. Samples for measuring blood lead levels were obtained from the
mothers antenatally, at delivery from the mothers and umbilical cords, and at the
ages of 6, 15, and 24 months and then annually from the children. Concurrently,
the mothers were interviewed about personal, family, medical, and environmental
factors. Maternal intelligence, the home environment, and the children's mental
development (as evaluated with use of the McCarthy Scales of Children's Abili-
ties) were formally assessed.
The mean blood lead concentration varied from 9.1 µg/dt in midpregnancy to a
peak of 21.2 µg/dl at the age of 2 years. The blood lead concentration at each age,
particularly at 2 and 3 years, and the integrated postnatal average concentration
were inversely related to development at the age of 4. Results of multivariate

LEAD AND HUMAN HEALTH
120
104
13
6 12 18 24
AGE AT TESTING (monttts)
Fae. 7. Prenatal exposure to lead, as measured by umbilical cord blood lead levels vs early mental
development index. Low is c3 µg/dl, medium is 6.7 µp'dt, and high is a 10 ;Wdl (Bellinger et al..
1987).
analysis are illustrated in Fig. 8. Within the range of exposure studied, no thresh-
old:dose for an effect of lead was evident.
This cohort study indicates that a raised blood lead concentration in early
childhood has an independent deleterious effect on mental development as eval-
uated at the age of 4 years. This effect was not accounted for by the known and
measurable influences of obstetrical, parental, family, and social environmental
factors on mental development. The results of this analysis and those of an earlier
analysis of the children at the age of 2 years suggest that increased exposure to
lead results in a developmental deficit, not just developmental delay.
Bhattacharya et al. (1988) found that abnormalities in children's abilities to
maintain physical balance were significantly associated with PbB. Their postural
sway on a balance increased by -2.8 cm2lµg/dl. These data suggest that low levels
of PbB affect the peripheral nervous system as well as the central nervous system.
A sample of their results are illustrated in Fig. 9.
Schwartz and Otto (1987) used the large database available from the Second
National Health and Nutrition Examination Survey (NHANES II), conducted
between E976 and 1980 on population samples selected as being representative of
the civilian, noninstitutionalized U.S. population. For a subsample of 4519 youths
ages 4-19 years, there were data available on blood Pb, audiometry, and various
indicators of neurological development, such as age at which a child first sat up,
walked, and spoke. The presence of speech difficulties and hyperactivity was also

14 MORTON LIPPMANN
120
110
I , %
Mccarthy scal.:
m ! V 1
.. . _ ~ ...._~_.
~ 1M .a QUal1tI~wi
W tatIVe
n D.....~ e~~
~ (GCi)
90 Mmory
Mctor
50
40
0.5
10.3
1.0 1.5 2.0 µmot/1
20.6 30.9 41.2 µg / d
Blood Lead Concentration ,,,,,,,,,,,,k,,ch,,,,,, n,U)
Fte. 8. McCarthy scales of children's abilities (MSCA) scores at the age of 4 vs blood lead con-
centration at 3 years of a=e (McMichael et ot.. 1988).
examined to determine if they were significantly related to lead exposure. The
probability of elevated hearing thresholds a4 500, 1000, 2000, and 4000 Hz in-
creased significantly (P < 0.0001) with increasing PbB (Fig. 10). PbB levels were
also significantly related to delays in the age at which children first sat up (Fig.
11), walked, and spoke and to the probability that a child was hyperactive. Lead
was not related to the probability of a child having a previously diagnosed speech
impairment.
Table 3 shows the variables considered in the stepwise multiple regressions,
while Table 4 shows the levels of significance of the associations between blood
lead and the developmental variables. The results of this large population study
are clearly consistent with, and strongly supportive of, the validity of the asso-
ciations between blood lead and neurobehavioral effects in the smatler popula-
tions reviewed earlier.
In another examination of NHANES 11 data, Schwartz tt ol. (1986) incorpo-
rated medical history, physical examination, anthropometric measurements, di-
etary information (24-hr recall and food frequency), labbratory tests, and radio-
graphs in linear regressions of adjusted data from 2695 children ages 7 years and
younger. They reported that 91% of the variance in height, 72% of the variance in
weight, and 58% of the variance in chest circumference (Fig. 12) were explained
by six variables: age, race, sex, blood lead level, total calories or protein, and
hcmatocrit or transferrin saturation level.
In summary, there are a number of well-designed studies which indicate that
very low levels of exposure to lead affect neurobehavioral function and develop-
ment in young children. nese various effects appear to be consistent with the

LEAD AND HUMAN HEALTH
~ TEST CONDITION: EYES CLOSED, NO FOAM
(p . 0.0025, r Z. 0.41)
0
1.6
0
M
®
® (uea of swayl-1.49 - o.00002 fntirt w presw.t
~-01 1 (lop maz PDe i+ i a yr.l + o.e9lbp m= Pb8 n 2td yr.1
I 1 I
I I I I I I I r I
1.4
2.0 2.4 2.8 3.2 3.6
Log Max. PbB Durinp S®cond Year of Life (µp / d)
4.0
15
Fto. 9. National logarithm of postural sway of children at 6 years of age vs natural log blood lead
concentration during second year of tife after controlling for blood lead during first year of life
(Bhattacharya et al., 1988).
effects of lead on heme biosynthesis which have been postulated to lead to eryth-
ropoaetic, neural, renal endocrine, and hepatic effects in the body, as summarized
in Fig. 13 from the 1986 EPA criteria document.
Effects ojl.ead in the Blood on Blood Pressure
Tlae 1986 EPA criteria document on lead also provided a critical review of
; studies showing associations between blood lead concentrations less than 40 µg/dl
and blood pressure. It reviewed the influence of a number of environmental and
nutritional factors affecting blood pressure in experimental and epidemiological
studies. Among environmental factors that have been associated with blood pres-
sures are lead (Pb) and noise. Among dietary factors associated with blood pres-
sure are calcium (Ca), zinc (Zn), phosphorus (P), alcohol consumption, and vita-
mins A and C.
The role of Pb as a pollutant stressor for elevated blood pressure could well be
confounded by the well-established role of Ca as a suppressor of blood pressure.
It is possible that persons with high Ca consumption have both decreased blood
pressure and reduced blood Pb due to the competition of both Pb and Ca for the
same binding sites. The influence of the other cofactors known to affect blood
pressure further complicates the task of establishing the extent to which Pb con-
stitutes a significant risk factor for elevated blood pressure.
A consistent pattern of results emerges from recent investigations of the rela-
tions between lower-level lead exposures and increases in blood pressure or hy-
pertension. pertension. Khera et a!. (1980) reported higher blood lead levels in hypertensive

16 MORTON LIPPMANN
~+ 11
m
v
a 4
*
Z
31 t 1 t 1 1
0 10 20 30 40 50
BLOOD LEAD LEVEL. µQ / d
Fto. 10. Relationship of 2 kHz pure tone hearing threshold (right eu) and blood levels in 4519
NHANES II subjects ages 4-19 years. Each point represents the mean hearing threshold of all persons
in a 3 µ" blood lead range, except for the last point, which represents the mean hearing threshold
and ysuan blood lead for all children with blood lead levels over 35 Wdl (Schwartz and Otto, 1987).
patients and those with other cardiovascular diseases than for hospital control
subjects. Kromhout and Couland (1984) and Kromhout et al. (1985) reported
associations between hypertension and blood lead among elderly men in the Neth-
erlands. Batuman et al. (1983) reported an association between hypertension and
chelatable lead burdens in veterans. Moreau et al. (1982) reported significant
associations (P < 0.001) between blood lead levels and a continuous measure of
blood pressure among French policemen after controlling for important potential
confounding variables such as age, body mass index, smoking, and drinking.
Weiss et al. (1986) reported that after correction for previous systolic blood pres-
sure, body mass index, age, and smoking, a high level of blood lead was a sig-
nificant predictor of subsequent elevation of systolic pressure in policemen in
Boston. Sharp et a!. (1988) examined relationships between blood lead concen-
tration and blood pressure in San Francisco bus drivers. The analysis was limited
to subjects not on treatment for hypertension (n = 288). The blood lead concen-
tration varied from 2 to 15 µg/dl. While the findings were not statistically signif-
icant, they did suggest effects of lead exposure at lower blood lead concentrations
than those previously linked with increases in blood pressure. In a follow-up
study, Sharp et al. (1989) examined the relationship between blood pressure and
blood lead concentration in 51 bus drivers who were treated for hypertension.
'These drivers were a subset of a representative sample (n = 342) of the driver
population (n r--2000) and were not selected for hypertension or lead exposure.
Blood lead concentrations ranged from 2 to 24 µg/dl. There were 33 subjects

LEAD AND HUMAN HEALTH
~
<
W
<
5.5
.3
®
17
®
1 1 1 t t t t 1 1
20 40 60 80 100
LEAD PERCENTILE RANK
FtG. I 1. Relationship of developmental mileston: attainment and blood lead levels in NHANES 11
subjects. Plots of age at which a child first sat up (in months) vs PbB, after adjusting for other
significant covariates. Each point represents the mean adjusted developmental index for 99 consecu-
tive observations ordered by mean blood lead level. Regression lines were derived from individual
data
(Schwarsz and Otto, 1987).
treated primarily with diuretics, and 18 subjects were treated with beta blockers.
There was a significant mean difference of 12 mm Hg in diastolic BP over the
range of observed Pb in blood (2.0 to 11.4 µg/dl) in subjects treated with beta
blockers (see Fig. 14). Thus, beta blocker therapy may be less effective in reduc-
TABLE 3
VARIAa1.ES C/SED /Ft STEPWISE REGRESSIOIiS
Rac.e
t.eM
Ear discharge
Cold in last 2 weeks
Other ear condition
Chronic ear discharge
Income
Dietary calcium
Race
Lead
Size
Dietary protein
. A. Audiometric analyses
Sex
Current cold
Ringing in ear{s)
Earache
Previous running ear
Diagnosed hearing impairment
Degree of urbanization
Head of household education level
Developmental milestone analyses
Sex
Income
Head of household education level
Total iron binding capacity
Transferrin saturation
Serum iron
Hemoglobin
Dietary calories
Weight

18
MORTON LIPPMANN
TABLE4
RESULTS OF DEVELOPMENTAL MILESTONE ANALYSES
Effect Coefficient P value
A. A41e (in years) at first word
Intercept
1.25
Sex -0.027 0.0277
Lead rank 0.0024 0.0094
B. Age (in months) when first walked
Intercept
10.E8
Rare -0.655 0.0006
Lead rank 0.0070 0.0020
C. Age (in months) when first tat up
Intercept
5.68
Protein intake -0.0039 0.0361
Lead rank 0.0061 0.0239
D. Probability of being hyperactive (log;stic regression)
Intercept
-4.503
-
Lead rank _ 0.0116 0.0130
ing diastolic pressure in individuals with elevated PbB, even at PbB levels asso-
ciated with exposures below the current ambient standard and far below the
current occupational standard.
In a large population study, Pocock et al. (1984) evaluated the relationships
between blood lead concentrations, hypertension, and renal function indicators in
a clinical survey of 7735 middle-aged men from 24 British towns. The association
~
W 55'50
U
Z
W
Q
~ 55.00
~
~
U
Q
U 5450
H
~
Wy
® 54.00
y
50
~ 53
S 10 15 20
'
ADJUSTED t3LOOD LEAD (Juq / d)
25
FIG. 12. Adjusted chest eircumference and adjusted blood lead levels for children ages 7 years and
younger in NHANES 11. Both chest circumference and blood lead level have been adjusted by
regression for effects of age, sex, and all other variables significant at 0.05 level. Each point is
mean
chest circumference and mean blood lead level for approximately 95 consecutive observations, or-
dered by blood lead levels. Regression line reflects slope of coefficient obtained from multiple
regres-
sion analyses of all 2671 points with no missinp data (Schwartz et al., 1986).

LEAD AND HUMAN HEALTH
EXACERBATION OF
HYPOXfC EFFECTS OF
OTHER STRESS AGENTS
EFFECTS ON
MEUHOMS,AXOP6 AND
SCHwANN CELLS
hicur~l
Effscts
REDUCED
HEMOPROTEINS
(e.g. CYTCCHROSIES)
F-++
I~PAJRED IMPAIRED
CELLULAR lfYEUFlATqN AND
ENERGET~CS kERVE CONDUCTION
t4lPA1RED
DEVELOPMENT
OF tdERVWS SYSTEM
R.w
Erdoaiiw
Eff~cta
REDUCED
125 {OH): -
ViTAMSN D
DISTURBED ttdMUHO f~IPAIRED
REGULATORY ROLE MINERAL T1SSW
OF CALCIUM FObtEOSTASfS
~---~+
DISTUABED RCIE
W
TUMORIGENESIS
CONTROL
Hcpatk
Etf~
REDUCED HEME FOR
HEME REGULATED
TRANSFORIdATiONS
-a
IMPAIRED G1LCtUY
ROIE AS SECOt~D
MESSENGER
CARDIOVASCULAR
DYSFUNCTION AND
OTHER HYPOXIC EFFECTS
utPAJRED BONE
AND TOOTH
DEVELOPIIENT
IMPAlRED CALCriJY
RO(E Dl CT'CLIC
MUCLEOTIDE METABOLISM
IMPAIRED DETOxnCAT10!!
OF XENO8JOTICS
IMPAIRED 61ETA80USIi
CF EHDOGENOtlS
AGOAnSTS
IMPAIRED
DETOXIFICATIOt OF
EHVIRONAtENTA1 TDX7kS
IMPAIRED
DETOXtFICAT10/1
OF DRUGS
r'1
ALTERED
METABOLISM
OF TRYPTOPMJW
ucPAfRED
1 HYDROXYLATBON
CF CORTISOL
ELEVATED BRAW
LEVELS OF TRYPTOPF{AN,
SEROTONiN AAD MAA
I
DISTURBED INDOLEAlAkE
NEUROTRANSAUTTER
FUNCTION
19
Fto. 13. Multiorgan impact of reductions of heme body pool by lead. Impairment of heme synthesis
by lead results in disruption of a wide variety of important physiotogical processes in many organs
and
tissues. Particularly weTl documented are erythropoietic, neural, renal-endocrine, and hepatic
effects
ii,dicated above by solid arrows. Plausible further consequences of heme synthesis interference by
k:ad are indicated by dashed arrows (EPA, 1956).
DISTURBED
CALCIUM
METABOLISM

MORTON LIPPMANN
.
6
s
0
0=14.3 tS.69ft"
10
- ADJUSTED Pa@.sg/dL (log scaii)
rto.14. Plot of adjusted diastolic blood pressure vs tdjusted natural lo& of blood lead
concentration
in male bus drivets treated for hypertension with beta blockers. Adjusted for age, aYe=, race, body
mass index, and frequencies of catfeine, akohol, and tobacco use. Diastolic blood pressure is the
average of three measured diastolic blood pressures on each subject (Sharp et at., 1989).
between systolic blood pressure and blood lead levels, though small in magnitude,
was statistically significant (P < 0.01). Analyses of data for men categorized
according to blood level concentrations indicated increases in blood pressure only
at lower blood lead levels; no further significant increments in blood pressure
were observed at higher blood lead levels.
~t t t I I I I I I t
5 15 25 35 45
BLOOD LEAD LEVEL (Np / d)
6'ia. 15. Adjusted diastolic blood pressure and adjusted blood lead levels for males ages 20 to 74
from NHANES Il. Both blood pressure and blood lead were adjusted by regression for the effects o[
age, age', body mass, and other significant variables. Each point represents the mean blood pressure
and mean blood lead for 50 consecutive observations, sorted in increasing order of blood lead
(Schwartz, t488).
